These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34837093)

  • 1. "Borderline" epithelial lesions of the breast: what have we learned in the past three decades?
    Sapino A; Marchiò C; Kulka J
    Pathologica; 2021 Oct; 113(5):354-359. PubMed ID: 34837093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
    McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N
    Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
    Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
    Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline epithelial lesions of the breast.
    Rosai J
    Am J Surg Pathol; 1991 Mar; 15(3):209-21. PubMed ID: 1847606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure flat epithelial atypia is uncommon in subsequent breast excisions for atypical epithelial proliferation.
    Yamaguchi R; Tanaka M; Tse GM; Yamaguchi M; Terasaki H; Akiba J; Naito Y; Mizushima Y; Yano H
    Cancer Sci; 2012 Aug; 103(8):1580-5. PubMed ID: 22533984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy.
    Prowler VL; Joh JE; Acs G; Kiluk JV; Laronga C; Khakpour N; Lee MC
    Breast; 2014 Aug; 23(4):352-6. PubMed ID: 24518220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Do We Approach Benign Proliferative Lesions?
    Nakhlis F
    Curr Oncol Rep; 2018 Mar; 20(4):34. PubMed ID: 29572753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypia in breast pathology: what pathologists need to know.
    Katayama A; Toss MS; Parkin M; Ellis IO; Quinn C; Rakha EA
    Pathology; 2022 Feb; 54(1):20-31. PubMed ID: 34872753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobular neoplasia: frequency and association with other breast lesions.
    Gomes DS; Balabram D; Porto SS; Gobbi H
    Diagn Pathol; 2011 Aug; 6():74. PubMed ID: 21827679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions.
    Tonegutti M; Girardi V
    Radiol Med; 2008 Feb; 113(1):65-75. PubMed ID: 18338128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
    Gomes DS; Porto SS; Balabram D; Gobbi H
    Diagn Pathol; 2014 Jun; 9():121. PubMed ID: 24948027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy.
    Srour MK; Donovan C; Chung A; Harit A; Dadmanesh F; Giuliano AE; Amersi F
    Breast J; 2020 Apr; 26(4):679-684. PubMed ID: 31562689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
    Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
    Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.
    Hartmann LC; Radisky DC; Frost MH; Santen RJ; Vierkant RA; Benetti LL; Tarabishy Y; Ghosh K; Visscher DW; Degnim AC
    Cancer Prev Res (Phila); 2014 Feb; 7(2):211-7. PubMed ID: 24480577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy.
    Irfan K; Brem RF
    Breast J; 2002; 8(4):230-3. PubMed ID: 12100116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study.
    Uzoaru I; Morgan BR; Liu ZG; Bellafiore FJ; Gaudier FS; Lo JV; Pakzad K
    Virchows Arch; 2012 Oct; 461(4):419-23. PubMed ID: 22961104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillomatous breast lesions with atypical columnar cell features.
    de Boer M; Verschuur-Maes AHJ; Moelans C; van Diest PJ
    J Clin Pathol; 2023 Apr; 76(4):228-233. PubMed ID: 36693714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.
    Kader T; Hill P; Zethoven M; Goode DL; Elder K; Thio N; Doyle M; Semple T; Sufyan W; Byrne DJ; Pang JB; Murugasu A; Miligy IM; Green AR; Rakha EA; Fox SB; Mann GB; Campbell IG; Gorringe KL
    J Pathol; 2019 Jul; 248(3):326-338. PubMed ID: 30843206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
    Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
    AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.